News and Insights

Print this page

Search News & Insights

Matheson advises Perella Weinberg Partners LP on Medtronic’s acquisition of Covidien

AUTHOR(S): Patrick Spicer, George Brady, Tim Scanlon
DATE: 16.06.2014

Matheson advised Perella Weinberg Partners LP on its role as financial adviser to US medical device maker Medtronic, Inc. on its $42.9 billion acquisition of Dublin-based Covidien plc. This deal was listed by Mergermarket as one of the top-5 global deals of H1 2014 

The Matheson team is led by corporate partners Patrick Spicer and George Brady as well as Tim Scanlon, head of Matheson’s Financial Institutions Group, and banking partner Libby Garvey.

This continues Matheson’s track record of advising on high profile international M&A transactions. Matheson advised Questcor Pharmaceuticals Inc on its $5.6 billion merger agreement with Mallinckrodt plc, which is due to complete in Q3 2014. Matheson also recently advised the US pharmaceutical firm Actavis plc on its $8.5 billion acquisition of Dublin-based Warner Chilcott plc and it advised Royalty Pharma on its $6.5 billion bid for Elan Corporation plc, the Irish biotechnology company. Matheson also advised Eaton Corporation plc on its $11.8 billion acquisition of Cooper Industries plc.

Matheson is the law firm of choice for international companies and financial institutions doing business in and through Ireland.


About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)